Stada Arzneimittel's Central and Eastern Europe sales region saw sales in this latest quarter plummet, hampered by the ongoing economic situation in Russia and Serbia. Of more comfort to Stada has been performance in Germany, which is showing evidence of countering the country's long-standing financial squeeze on generics. The domestic market is set to become increasingly important as a bulwark...
The evolving big pharma model is catalysing deep shifts within the CRO industry, with a move towards closer collaborative relationships. Whilst CROs initially attempted to draw in big pharma partnerships though size advantages, innovation is now becoming increasingly key. CROs that offer drug discovery solutions based on data-driven platforms will be of particular interest.
A member of our Client Services team will be in touch soon to arrange a convenient time for a free demonstration of the service. If your enquiry is urgent, please email our team here.
Thanks, BMI Research